Total Payments
$5,398
2024 Payments
$1,089
Companies
28
Transactions
373
Medicare Patients
944
Medicare Billing
$126,824
Payment Breakdown by Category
Food & Beverage$5,335 (98.8%)
Gifts$53.32 (1.0%)
Education$9.22 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,335 | 369 | 98.8% |
| Gift | $53.32 | 1 | 1.0% |
| Education | $9.22 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,407 | 121 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $581.23 | 36 | $0 (2024) |
| Janssen Biotech, Inc. | $521.20 | 35 | $0 (2024) |
| Gilead Sciences, Inc. | $475.97 | 31 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $471.44 | 35 | $0 (2024) |
| Celgene Corporation | $295.44 | 23 | $0 (2024) |
| PFIZER INC. | $260.72 | 15 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $197.09 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $162.19 | 10 | $0 (2023) |
| Braintree Laboratories, Inc. | $142.91 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,089 | 67 | ABBVIE INC. ($206.41) |
| 2023 | $851.67 | 64 | AbbVie Inc. ($227.19) |
| 2022 | $646.62 | 50 | ABBVIE INC. ($251.79) |
| 2021 | $777.83 | 64 | AbbVie Inc. ($241.17) |
| 2020 | $346.19 | 21 | Gilead Sciences, Inc. ($73.09) |
| 2019 | $639.32 | 34 | AbbVie, Inc. ($210.86) |
| 2018 | $669.72 | 48 | AbbVie, Inc. ($151.94) |
| 2017 | $377.72 | 25 | Valeant Pharmaceuticals North America LLC ($73.55) |
All Payment Transactions
373 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.94 | General |
| 12/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.86 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.24 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.85 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $16.95 | General |
| Category: GI | ||||||
| 11/11/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $6.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $9.99 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/28/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $4.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Gastroenterology | ||||||
| 10/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Immunology | ||||||
| 10/10/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/07/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $3.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/04/2024 | Ipsen Biopharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $18.05 | General |
| 09/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Immunology | ||||||
| 09/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $9.38 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.35 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/12/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.14 | General |
| Category: Neuroscience | ||||||
| 09/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/05/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 192 | 196 | $279,274 | $25,050 |
| 2022 | 9 | 274 | 279 | $357,751 | $36,939 |
| 2021 | 9 | 256 | 265 | $327,630 | $34,883 |
| 2020 | 7 | 222 | 226 | $300,872 | $29,953 |
Total Patients
944
Total Services
966
Medicare Billing
$126,824
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 63 | 63 | $122,921 | $11,986 | 9.8% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 30 | 32 | $45,429 | $3,620 | 8.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 46 | 46 | $57,021 | $3,298 | 5.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 11 | 11 | $13,452 | $1,844 | 13.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 17 | 18 | $30,861 | $1,726 | 5.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $5,432 | $1,330 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 14 | $4,158 | $1,246 | 30.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 84 | 84 | $153,300 | $15,765 | 10.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 57 | 58 | $68,962 | $4,562 | 6.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 19 | 19 | $21,204 | $3,254 | 15.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $9,372 | $2,644 | 28.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 15 | 15 | $16,740 | $2,485 | 14.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 25 | $6,975 | $2,258 | 32.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 26 | 26 | $42,120 | $2,236 | 5.3% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 16 | 19 | $25,878 | $2,225 | 8.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 11 | 11 | $13,200 | $1,511 | 11.4% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 82 | 82 | $149,650 | $15,756 | 10.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 20 | 20 | $22,320 | $3,497 | 15.7% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 40 | 41 | $48,749 | $3,203 | 6.6% |
| 43248 | Insertion of guide wire with dilation of esophagus using an endoscope | Facility | 2021 | 22 | 27 | $36,774 | $3,086 | 8.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 25 | $6,975 | $2,308 | 33.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2021 | 13 | 13 | $14,508 | $2,274 | 15.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $6,390 | $1,922 | 30.1% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 24 | 24 | $38,880 | $1,690 | 4.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 18 | $3,384 | $1,147 | 33.9% |
About Dr. Jeffrey Andreini, MD
Dr. Jeffrey Andreini, MD is a Gastroenterology healthcare provider based in Oshkosh, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2007. The National Provider Identifier (NPI) number assigned to this provider is 1235266735.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Andreini, MD has received a total of $5,398 in payments from pharmaceutical and medical device companies, with $1,089 received in 2024. These payments were reported across 373 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($5,335).
As a Medicare-enrolled provider, Andreini has provided services to 944 Medicare beneficiaries, totaling 966 services with total Medicare billing of $126,824. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Oshkosh, WI
- Active Since 02/28/2007
- Last Updated 07/08/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1235266735
Products in Payments
- STELARA (Biological) $382.68
- ENTYVIO (Biological) $380.46
- LINZESS (Drug) $332.96
- XIFAXAN (Drug) $297.29
- ZEPOSIA (Drug) $288.88
- VIBERZI (Drug) $250.78
- XELJANZ (Drug) $209.49
- Humira (Biological) $185.91
- TRULANCE (Drug) $164.07
- RINVOQ (Biological) $153.88
- SKYRIZI (Biological) $150.50
- Linzess (Drug) $138.90
- HUMIRA (Biological) $137.05
- DIFICID (Drug) $101.37
- Cimzia (Drug) $92.32
- TREMFYA (Drug) $89.61
- CLENPIQ (Drug) $77.73
- Amitiza (Drug) $75.81
- Creon (Drug) $69.71
- Mavyret (Drug) $68.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.